Pharmaceutical industry news

AstraZeneca’s Etcamah falls short of key Phase III endpoint in breast cancer trial

Ανάκληση του αριθμού παρτίδας 14 L156 D της βρεφικής τροφής με ονομασία πώλησης “Bio/Organic Apple-Peach-Mango, 6+ months” και εμπορική ονομασία “LUPILU”

India’s biotech growth needs more long-term capital, says expert

This Week in Science: Poop Concrete, Hot Ice, And More!

Singapore launches biotech-focused Boston hub to build on 'centuries-old bond'

Frazier adds $1.1B+ to small and mid-sized biotech fund

Kenya's wealthy Merali family acquires stake in pharmaceutical glass plant

Eppendorf launches refrigerated Centrifuge 5811 R

Report an outbreak of acute respiratory infection in an adult social care setting

You can use this service to report an outbreak if you provide adult social care. This includes a car...

Should You Bet Big on Drugmakers? VanEck Pharmaceutical ETF vs. Invesco Healthcare ETF Compared.

The Download: biotech’s future and cheaper, cleaner steel

Sterlitech launches benchtop membrane filtration systems

FDA extends review of Exelixis drug application for metastatic colorectal cancer

The tadpoles that don't care about their siblings

Kyoto University signs agreement with Taiwan's Ministry of Education regarding the Taiwan Global Pathfinders Initiative

Profitable Biotech Incyte Forms Handle As Institutional Buyers Load Up On Stock

Transition of the Icelandic Medicines Agency’s Website in Full Swing

mRNA cancer vaccines’ biggest barriers to market

U.S. FDA extends review of Exelixis’ cancer drug

ANMAT evaluó y liberó más de 430 lotes de vacunas entre junio de 2025 y mayo de 2026

België moet nu investeren in digitale pathologie om morgen betere zorg te bieden

FDA Extends Review Timeline for Exelixis Cancer Drug

Frost & Sullivan presents the "GLOBAL GENE THERAPY CRDMO TECHNOLOGY INNOVATION LEADERSHIP AWARD" to PackGene Biotech Inc.

Moins de papier, plus de numérique : nous faisons évoluer nos pratiques !

‘It Restored My Hope’: How the Margaret Foti Scholarship Helped Tsedey Tsegaye Reclaim Her Future

Biohaven’s epilepsy drug hit with FDA clinical hold

How Investors May Respond To SELLAS Life Sciences Group (SLS) Phase 3 Trial Nears

The Early Scale: CPC Biotech and Multiply Labs smoothen cell therapy automation bottleneck

Shanghai Henlius Biotech Says NDA For 120 Mg Biosimilar Denosumab HLX14 Accepted By NMPA

MRKON Risks Explained: KEYTRUDA Dependence, Patent Expiry, Clinical Trials and Tokenized Stock Risk

Poland's case against EU wastewater rules boosted by Advocate General opinion

Angelman drug partner for Research Alliance III (RACC) eyes 2029 data

Set Yourself Up for a Strong 2027: 2 Pharmaceutical Stocks to Buy in September

AstraZeneca shares phase 3 results for Imfinzi plus Imdelltra in extensive-stage small cell lung cancer

From Tartan Army to biotech – deepening Scotland’s ties with Boston through new life sciences partnership

Heidelberger Medizin-Studierende weiter absolute Spitze in Deutschland

AZ’s COPD drug cuts flare-ups in two phase 3 trials

Set Yourself Up for a Strong 2027: 2 Pharmaceutical Stocks to Buy in September

Head of German venture fund sees big potential in Danish biotech – but investors are lacking

Are you working with the non-clinical package for clinical trial applications? See Q&A-update!

Government and Innovate UK back creative technology growth

Rewriting the rules of genetic medicine with tRNA therapeutics｜Beyond Biotech

Trial misses prompt shake-up call from major Novartis stockholder

What regulators ask when AI touches a drug application

Key approvals, positive study results and a partnership deal to fast track new medications

Shanghai Henlius Biotech, Inc. Announces Acceptance Of New Drug Application For 120 Mg (1.7 Ml) Per Vial Strength Of Biosimilar Of Denosumab HLX14

AbbVie drug meets phase 3 goal in menstrual migraine

Meet the under-35s shaping the future of biotech

Aprecia Pharmaceuticals: 'AM is an important expansion of the pharmaceutical manufacturing toolbox'

Anavex Life Sciences to discuss pediatric inclusion in Rett syndrome trial By Investing.com

Biotech for Climate Resilience Fund

[Reporter’s Notebook] K-biopharma licensing deals are getting better, not just bigger

Weekly all-cause mortality surveillance: week ending 13 September 2026

How the actual number of deaths in England compare with expected numbers for each week.

Astadaily earns Purity Award from Clean Label Project

KEMRI Shines & Clinches Top Awards at 2026 Mombasa Show

JPMorgan initiates Dianthus stock at Overweight, $135 target

[Reporter’s Notebook] K-biopharma licensing deals are getting better, not just bigger

Biotech students must step out of comfort zones, embrace multiple roles: Suchitra Ella

Ny musikstudio – en fristad för psykiatrins patienter på Östra sjukhuset

Can Our Homes Beat the Heat? HOMES Study Shares Findings with Industry players.